FDA Approved
Erchonia lasers are the first and only LLLT devices with multiple FDA clearances.
Erchonia holds 22 FDA clearances for their LLLT products
Backed by Level 1 clinical studies (gold standard)
20+ years of research in neurology, orthopedics, aesthetics, and more
Lower Back Pain
FDA Approved
About 80 percent of adults experience low back pain at some point in their lifetimes. Of those, about 60% are treated with opioids, despite the opioid epidemic and minimum effectiveness (30%). Erchonia’s FX 635 laser showed a 72% success rate in their clinical trial, which received FDA market clearance in May 2018. The FX 635 treatment of chronic low back pain is groundbreaking in the pain management community and give patients a safer, more effective treatment option that will get them back on their feet in no time.
